These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 31239268)
1. TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression. Wang S; Zhang Y; Huang J; Wong CC; Zhai J; Li C; Wei G; Zhao L; Wang G; Wei H; Zhao Z; Yu J Cancer Res; 2019 Aug; 79(16):4086-4098. PubMed ID: 31239268 [TBL] [Abstract][Full Text] [Related]
2. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway. Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720 [TBL] [Abstract][Full Text] [Related]
3. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028 [TBL] [Abstract][Full Text] [Related]
4. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53. Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734 [TBL] [Abstract][Full Text] [Related]
5. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis. Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986 [TBL] [Abstract][Full Text] [Related]
6. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop. Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750 [TBL] [Abstract][Full Text] [Related]
7. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation. Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406 [TBL] [Abstract][Full Text] [Related]
8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
9. The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. Menon S; Goldfarb D; Ho CT; Cloer EW; Boyer NP; Hardie C; Bock AJ; Johnson EC; Anil J; Major MB; Gupton SL Mol Biol Cell; 2021 Feb; 32(4):314-330. PubMed ID: 33378226 [TBL] [Abstract][Full Text] [Related]
10. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel. Guo J; Yang Y; Yang Y; Linghu E; Zhan Q; Brock MV; Herman JG; Zhang B; Guo M Oncotarget; 2015 Feb; 6(6):4202-13. PubMed ID: 25638156 [TBL] [Abstract][Full Text] [Related]
11. TRIM67 Suppresses TNFalpha-Triggered NF-kB Activation by Competitively Binding Beta-TrCP to IkBa. Fan W; Liu X; Zhang J; Qin L; Du J; Li X; Qian S; Chen H; Qian P Front Immunol; 2022; 13():793147. PubMed ID: 35273593 [TBL] [Abstract][Full Text] [Related]
12. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis. Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838 [TBL] [Abstract][Full Text] [Related]
13. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway. Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786 [TBL] [Abstract][Full Text] [Related]
15. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. Liu S; Tackmann NR; Yang J; Zhang Y Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib Stabilizes and Activates p53 in Proliferative Compartments of Both Normal and Tumor Tissues Xue Y; Barker N; Hoon S; He P; Thakur T; Abdeen SR; Maruthappan P; Ghadessy FJ; Lane DP Cancer Res; 2019 Jul; 79(14):3595-3607. PubMed ID: 31138526 [TBL] [Abstract][Full Text] [Related]
17. Ameliorating Effects of Luo Q; Jahangir A; He J; Huang C; Xia Y; Jia L; Wei X; Pan T; Du Y; Mu B; Gong H; Liu W; Ur-Rehman S; Pan K; Chen Z Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887011 [TBL] [Abstract][Full Text] [Related]
18. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Ghosh JC; Altieri DC Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644 [TBL] [Abstract][Full Text] [Related]
19. A Novel Inhibitor Targets Both Wnt Signaling and ATM/p53 in Colorectal Cancer. Cheng J; Dwyer M; Okolotowicz KJ; Mercola M; Cashman JR Cancer Res; 2018 Sep; 78(17):5072-5083. PubMed ID: 30032112 [TBL] [Abstract][Full Text] [Related]
20. 8-Acetonyldihydronitidine inhibits the proliferation of human colorectal cancer cells via activation of p53. Zhou J; Li Z; Zhang J; Wang H; Yin S; Du J Eur J Pharmacol; 2019 Jul; 854():256-264. PubMed ID: 30928633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]